Actively Recruiting
Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.
Led by University Hospital, Clermont-Ferrand · Updated on 2024-07-08
200
Participants Needed
7
Research Sites
229 weeks
Total Duration
On this page
Sponsors
U
University Hospital, Clermont-Ferrand
Lead Sponsor
P
PANZANI
Collaborating Sponsor
AI-Summary
What this Trial Is About
Subclinical intestinal inflammation and gut dysbiosis have been reported in patients with spondyloarthritis (SpA). In common practice, rheumatologists are increasingly confronted with patients with inflammatory rheumatism who are on gluten-free diets (GFDs), despite the lack of reliable data from controlled studies. This study aims to determine the impact of a GFD on the quality of life of patients with axial SpA.
CONDITIONS
Official Title
Impact of a Gluten-free Diet on Quality of Life in Patients With Axial Spondyloarthritis.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of axial spondyloarthritis defined by ASAS criteria
- Rheumatologist does not plan to change treatment within 4 months of inclusion
- Stable treatment with NSAIDs and/or DMARDs for at least 3 months
- No corticosteroid infiltration in the month prior to inclusion
- Ability to follow a gluten-free diet and provide written informed consent
- Willingness to comply with all study requirements
You will not qualify if you...
- Following any special diet at inclusion or within 3 months prior
- History of celiac disease
- Use of antibiotics within 3 months prior or current probiotic use
- Pregnant or breastfeeding
- Not covered by social security
- Minors or adults under legal protection or guardianship
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
CHU de Bordeaux
Bordeaux, France, 33000
Not Yet Recruiting
2
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000
Actively Recruiting
3
CHU de Grenoble
Grenoble, France, 38000
Not Yet Recruiting
4
Hospices Civils de Lyon
Lyon, France, 69000
Not Yet Recruiting
5
CHU de Montpellier
Montpellier, France, 34000
Not Yet Recruiting
6
Assistance Publique - Hôpitaux de Paris (AP-HP) - Hôpital Cochin
Paris, France, 75000
Not Yet Recruiting
7
CHU de Saint-Etienne
Saint-Etienne, France, 42000
Not Yet Recruiting
Research Team
L
Lise Laclautre, Pharm D
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here